Those taking the drugs for at least three years cut their risk of heart attack, stroke or cardiac death by 20 per cent ...
Obesity jabs could cut the risk of heart attacks and strokes in people even if they fail to lose much weight, according to an ...
Patients taking semaglutide had a 20% lower risk of heart attack, stroke or death due to cardiovascular disease after three ...
Find your bookmarks in your Independent Premium section, under my profile Weight loss jabs like Ozempic can cut the risk of heart attacks or strokes by a fifth, a “game-changing” new study has ...
Marketed as Wegovy, Ozempic and Rybelsus, semaglutide injections may benefit obese patients even if they don't lose weight.
Weight loss jabs like Ozempic cuts risk of heart attack and stroke by fifth, ‘game-changing’ study finds - Risk of serious ...
Ozempic could dramatically reduce the risk of heart attacks and stroke, a new study indicates. The weight loss jab has become ...
Semaglutide once a week reduced risk of adverse outcomes in kidney patients by 24 percent, finds study published in The New ...
As a major study shows it cuts heart attack risks experts say semaglutide could 'transform many chronic diseases of ageing' ...